Want to see KR:006280 full AI Analyst Report?
GC Biopharma Corp. (006280) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Nov 03, 2026
- Period Ending
- 2026 (Q3)
- Consensus EPS Forecast
- ―
- Last Year’s EPS
- 1364.76
TBA (Not Confirmed)
Same Quarter Last Year
GC Biopharma Corp. (KR:006280) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
KR:006280 Q2 2026 Earnings Report
KR:006280 Upcoming Earnings
GC Biopharma Corp.'s next earnings date is estimated for November 3, 2026, based on past reporting schedules.
KR:006280 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 03, 2026 | 2026 (Q3) | ―- | 1364.76 | ― | ― | ― | ― |
| Jul 31, 2026 | 2026 (Q2) | 973.79169.42 | 3250.62 | -94.79% (-3081.20) | ― | ― | |
| May 08, 2026 | 2026 (Q1) | -126.201751.52 | 2541.29 | -31.08% (-789.77) | ― | ― | |
| Mar 18, 2026 | 2025 (Q4) | -3201.46-7555.40 | -2335.07 | -223.56% (-5220.33) | ― | ― | |
| Nov 03, 2025 | 2025 (Q3) | 204.791364.76 | 2845.9 | -52.04% (-1481.14) | ― | ― | |
| Aug 01, 2025 | 2025 (Q2) | 134.553250.62 | -607.68 | 634.93% (+3858.30) | ― | ― | |
| Apr 30, 2025 | 2025 (Q1) | -1049.152541.29 | -2217.83 | 214.58% (+4759.12) | ― | ― | |
| Mar 18, 2025 | 2024 (Q4) | -37.78-2335.07 | -1740.87 | -34.13% (-594.20) | ― | ― | |
| Nov 14, 2024 | 2024 (Q3) | ―2845.90 | 1219.8 | 133.31% (+1626.10) | ― | ― | |
| Aug 05, 2024 | 2024 (Q2) | ―-607.68 | 154.92 | -492.24% (-762.60) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
KR:006280 Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jul 31, 2026 | $115,900.00 | $113,300.00 | -2.24% |
| May 08, 2026 | $138,100.00 | $134,200.00 | -2.82% |
| Mar 18, 2026 | $149,401.00 | $143,757.61 | -3.78% |
| Nov 03, 2025 | $129,401.66 | $129,995.70 | +0.46% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does GC Biopharma Corp. (KR:006280) report earnings?
GC Biopharma Corp. (KR:006280) is estimated to report earnings on Nov 03, 2026, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.